Annual report pursuant to Section 13 and 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.21.1
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Accounts payable:    
Clinical and regulatory expenses $ 262 $ 232
Professional fees 252 1,183
Selling expenses 395 1,303
Manufacturing cost 596 4,541
Other vendors 518 18
Total accounts payable 2,023 7,277
Accrued interest payable, related parties 41 42
Accrued interest payable 627 991
Accrued expenses:    
Payroll expenses 1,053 891
Government rebates and other rebates 2,659 1,355
Due to EJ Holdings 545 238
Other accrued expenses 512 704
Total accrued expenses 4,769 3,188
Total accounts payable and accrued expenses $ 7,460 $ 11,498